Pharmacogenetics, adverse drug reactions and public health

被引：20

作者：

Kollek, R ^{[1
]}

van Aken, J ^{[1
]}

Feuerstein, G ^{[1
]}

Schmedders, M ^{[1
]}

机构：

[1] Univ Hamburg, FSP Biotech Gesell & Umwelt, DE-20251 Hamburg, Germany

来源：

COMMUNITY GENETICS | 2006年 / 9卷 / 01期

关键词：

adverse drug reactions; pharmacogenetics; public health; testing;

D O I：

10.1159/000090693

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Adverse drug reactions (ADRs) are a major public health problem. Pharmacogenetic testing prior to drug treatment is supposed to considerably alleviate this problem. The state of pharmacogenetic development was assessed by a systematic literature review, supplemented by expert interviews. Analysis of three case examples revealed that - with the exception of thiopurine methyltransferase (TPMT) - studies are lacking which unambiguously prove the clinical value of pharmacogenetic testing. Testing can prevent some, but by far not all ADRs. Since it does not compensate for clinical monitoring, pharmacogenetics can be regarded as add-on technology, applied in addition to established methods. A non-representative, explorative survey conducted amongst members of the German Society of Laboratory Medicine revealed that the demand for testing is limited and has not increased much, although a certain increase is expected in the future. Copyright (C) 2006 S. Karger AG, Basel.

引用

页码：50 / 54

页数：5

共 50 条

[41] Identification and reduction of adverse drug reactions [J].

Thompson, Dennis F. ;

Sharp, Randall P. .

JOURNAL OF HEALTHCARE LEADERSHIP, 2010, 2 :43-48

[42] Adverse drug reactions: managing the risk [J].

Jordan, Sue ;

Jones, Richard ;

Sargeant, Matthew P. .

JOURNAL OF NURSING MANAGEMENT, 2009, 17 (02) :175-184

[43] Adverse drug reactions and hospital admissions [J].

Reactions Weekly, 2002, 908 (1) :4-4

[44] Adverse Drug Reactions in Patients with CKD [J].

Laville, Solene M. ;

Gras-Champel, Valerie ;

Moragny, Julien ;

Metzger, Marie ;

Jacquelinet, Christian ;

Combe, Christian ;

Fouque, Denis ;

Laville, Maurice ;

Frimat, Luc ;

Robinson, Bruce M. ;

Stengel, Benedicte ;

Massy, Ziad A. ;

Liabeuf, Sophie .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (08) :1090-1102

[45] Ranking Adverse Drug Reactions With Crowdsourcing [J].

Gottlieb, Assaf ;

Hoehndorf, Robert ;

Dumontier, Michel ;

Altman, Russ B. .

JOURNAL OF MEDICAL INTERNET RESEARCH, 2015, 17 (03)

[46] Adverse drug reactions in elderly patients [J].

Routledge, PA ;

O'Mahony, MS ;

Woodhouse, KW .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (02) :121-126

[47] Adverse drug reactions in older people [J].

Tangiisuran, B. ;

Gozzoli, M. P. ;

Davies, J. G. ;

Rajkumar, C. .

REVIEWS IN CLINICAL GERONTOLOGY, 2010, 20 (03) :246-259

[48] Adverse drug reactions to antiretroviral medication [J].

Roca, Bernardino .

FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 :1785-1792

[49] Editorial: Pharmacogenomics of Adverse Drug Reactions [J].

Siddiqui, Moneeza K. ;

Luzum, Jasmine ;

Coenen, Marieke ;

Mahmoudpour, Seyed Hamidreza .

FRONTIERS IN GENETICS, 2022, 13

[50] Adverse drug reactions and Alzheimer disease [J].

Piau, A. ;

Nourhashemi, F. ;

Vellas, B. .

REVUE DE MEDECINE INTERNE, 2009, 30 :S302-S306

← 1 2 3 4 5 →